ISBN-13: 9783319208244 / Angielski / Twarda / 2015 / 475 str.
There is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced "autoprotection," for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced "autoimpairment." This volume describes the physiology, pathophysiology and pharmacology of the endocannabinoid system and potential strategies for targeting this system in the clinic.